Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Diversified Healthcare Trust (DHC) SEC Filings & Earnings Calls

EquiReason read 17 Diversified Healthcare Trust SEC filings in the last 12 months. Latest: SC 13D/A on 2026-08-12 — H/2 Special Opportunities IV L.P. reduced its stake in Diversified Healthcare Trust to below 5%, selling 750,000 shares, indicating reduced conviction or exit..

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

DHCDiversified Healthcare TrustFollow DHC — free
REIT - Healthcare Facilities · Real Estate
—
Price chart with a free account
Market cap
1.9B
P/E TTM
—
Dividend yield
0.5%
52-week
—
Next earnings
2 Nov, in 9 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

12 Aug 2026SC 13D/AH/2 Special Opportunities IV L.P. reduced its stake in Diversified Healthcare Trust to below 5%, selling 750,000 shares, indicating reduced conviction or exit.open

Figures in the filing · each found in the filing text

Beneficial ownership percentage · 2026-08-105.0%
Read the original on SEC EDGAR ↗
12 Aug 2026SC 13D/AH/2 Special Opportunities IV L.P. reduced its stake in Diversified Healthcare Trust to below 5%, selling 750,000 shares, indicating reduced conviction or exit.open

Figures in the filing · each found in the filing text

Beneficial ownership percentage · 2026-08-105.0%
Read the original on SEC EDGAR ↗
3 Aug 20268-K · 2.02DHC reports strong Q2 2026: same property SHOP NOI up 37.2% YoY, occupancy up 160 bps, NOI margin up 390 bps, net debt/EBITDAre improved to 7.1x from 8.7x YoY.earningsopen

Figures in the filing · each found in the filing text

Same Property Cash Basis NOI - SHOP · SHOP · Q2-2026$52M+37% y/y
Same Property Occupancy - SHOP · SHOP · Q2-202683.1%
Same Property Cash Basis NOI - Medical Office and Life Science · Medical Office and Life Science · Q2-2026$24M-1% y/y
Same Property Occupancy - Medical Office and Life Science · Medical Office and Life Science · Q2-202695.8%
Adjusted EBITDAre · Q2-2026$82M+12% y/y
Consolidated NOI · Q2-2026$84M+20% y/y
Net Debt to Annualized Adjusted EBITDAre · Q2-2026$7.10-18% y/y
Normalized FFO per Share · Q2-2026$0.16
Net Loss per Share · Q2-2026$-0.16
Total Liquidity · Q2-2026$267M

Risks flagged

Net loss persists despite operational improvements

“Net loss of $37.4M in Q2 2026”

Medical Office and Life Science NOI declined slightly YoY

“Same Property Cash Basis NOI Medical Office and Life Science Portfolio decreased 1.3% YoY”
Read the original on SEC EDGAR ↗
3 Aug 202610-QDiversified Healthcare Trust reported Q2 2026 results with strong SHOP segment performance (NOI +37%) but overall net loss improved to $37M from $92M.earningsopen

Figures in the filing · each found in the filing text

SHOP comparable occupancy · SHOP · Q2-202683.1%
SHOP average monthly rate · SHOP · Q2-2026$5715.00+6% y/y
SHOP comparable NOI · SHOP · Q2-2026$52M+37% y/y
Medical Office and Life Science comparable occupancy · Medical Office and Life Science · Q2-202695.8%
Total revenues · Q2-2026$365M-5% y/y
Net loss · Q2-2026$-37M+59% y/y

Risks flagged

Labor cost inflation

“Property operating expenses increased at our comparable properties primarily due to increases in labor costs, management fees as a result of higher revenues and insurance costs” · word for word

Interest rate sensitivity

“We are closely monitoring the impacts of the current economic and market conditions on all aspects of our business, including, but not limited to, uncertainties surrounding interest rates and inflation” · word for word

Disposition/transition execution risk

“During the three months ended June 30, 2026, we incurred transition costs as a result of our transition of 116 communities to both new and existing third party managers.” · word for word
Read the original on SEC EDGAR ↗
1 Jun 20268-K · 7.01Issued a Regulation FD disclosure (forward guidance or material update); filed financial statements and exhibits with this reportSEC ↗
5 May 20268-K · 7.01Issued a Regulation FD disclosure (forward guidance or material update); filed financial statements and exhibits with this reportSEC ↗
4 May 20268-K · 2.02Same Property Cash Basis NOI - SHOP $44M (+14% y/y); Same Property Occupancy - SHOP 82.4; Same Property Cash Basis NOI - Medical Office and Life Science $25M (+3% y/y); Guidance: Expects 26% to 33% SHOP NOI growth in 2026earningsopen

Figures in the filing · each found in the filing text

Same Property Cash Basis NOI - SHOP · SHOP · Q1-2026$44M+14% y/y
Same Property Occupancy - SHOP · SHOP · Q1-202682.4%
Same Property Cash Basis NOI - Medical Office and Life Science · Medical Office and Life Science · Q1-2026$25M+3% y/y
Same Property Occupancy - Medical Office and Life Science · Medical Office and Life Science · Q1-202695.3%
Consolidated NOI · Q1-2026$76M+9% y/y
Adjusted EBITDAre · Q1-2026$74M
Net Loss · Q1-2026$-43M
Normalized FFO · Q1-2026$33M+131% y/y
Total Revenues · Q1-2026$366M
Net Debt to Annualized Adjusted EBITDAre · Q1-2026$7.80

Guidance

Expects 26% to 33% SHOP NOI growth in 2026

CEO explicitly guides strong SHOP NOI growth for 2026, supported by operational milestones and capital investments.

Risks flagged

Leverage remains elevated at 7.8x, though improving.

“Net Debt to Annualized Adjusted EBITDAre 7.8x”

Net loss of $43.3M indicates ongoing profitability challenges.

“Net Loss $(43.3)M”
Read the original on SEC EDGAR ↗
4 May 202610-QTotal NOI $76M (+5% y/y); SHOP NOI $44M (+18% y/y); SHOP comparable occupancy 82.4open

Figures in the filing · each found in the filing text

Total NOI · Q1-2026$76M+5% y/y
SHOP NOI · SHOP · Q1-2026$44M+18% y/y
SHOP comparable occupancy · SHOP · Q1-202682.4%
SHOP average monthly rate · SHOP · Q1-2026$5656.00+6% y/y
Medical Office and Life Science comparable NOI · Medical Office and Life Science Portfolio · Q1-2026$25M+4% y/y
Medical Office and Life Science comparable occupancy · Medical Office and Life Science Portfolio · Q1-202695.3%
Net loss · Q1-2026$-43M
Interest expense · Q1-2026$37M-36% y/y

Risks flagged

Labor cost inflation in SHOP segment

“Property operating expenses increased at our comparable properties primarily due to increases in labor costs, management fees as a result of higher revenues, insurance costs and other direct costs.” · word for word

Interest rate and refinancing risk

“We are closely monitoring the impacts of the current economic and market conditions on all aspects of our business, including, but not limited to, uncertainties surrounding interest rates and inflation.” · word for word
Read the original on SEC EDGAR ↗
19 Mar 2026DEF 14AAnnual proxy statement with executive compensation disclosure and shareholder proposals.open

Figures in the filing · each found in the filing text

Total Shareholder Return · FY2025113.0%
Occupancy Rate - Office Portfolio · Office Portfolio · 2025-12-3185.7%
Occupancy Rate - SHOP · SHOP · 2025-12-3178.1%
Number of Assets - Office Portfolio · Office Portfolio · 2025-12-31102
Number of Assets - SHOP · SHOP · 2025-12-31232
Gross Proceeds from Property Sales · FY2025$605M
Net Income (Loss) · FY2025$-286M

Risks flagged

SHOP operational transition risk

“We transitioned 116 SHOP communities formerly managed by AlerisLife to a diversified group of new operators.” · word for word

Concentration of insider ownership

“All Trustees, Trustee nominees and executive officers as a group (eight persons) 24,583,566 10.15%” · word for word
Read the original on SEC EDGAR ↗
24 Feb 20268-K · 7.01Issued a Regulation FD disclosure (forward guidance or material update); filed financial statements and exhibits with this reportopen

Guidance

Presentation reaffirms 2026 guidance with expectations for NOI, Normalized FFO, occupancy, and margin growth, but no specific numbers provided.

Risks flagged

Forward-looking statements contain extensive boilerplate risks including market conditions, interest rates, inflation, supply chain, tariffs, geopolitical tensions, and labor market conditions.

“Risks include: unfavorable market and commercial real estate industry conditions, uncertainties surrounding interest rates, wage and commodity price inflation, supply chain disruptions, changing tariffs and trade policies, geopolitical instability, pandemics, economic downturns, labor market conditions”
Read the original on SEC EDGAR ↗
24 Feb 202610-KNumber of properties owned 298; Number of senior living communities 212; Medical office and life science JV rentable square feet 2,200,000open

Figures in the filing · each found in the filing text

Number of properties owned · 2025-12-31298
Number of senior living communities · senior living · 2025-12-31212
Medical office and life science JV rentable square feet · medical office and life science · 2025-12-312,200,000
Medical office and life science JV occupancy · medical office and life science · 2025-12-3199.0%
Medical office and life science JV average remaining lease term · medical office and life science · 2025-12-31$14.20
AlerisLife dividend received (pro rata) · 2026-01-09$27M

Guidance

Management expects improving market fundamentals and constrained supply to drive occupancy growth, but no specific financial guidance provided.

Risks flagged

Medicaid Funding Cut Risk

“On July 4, 2025, the U.S. government enacted Public Law No. 119-21, commonly known as the One Big Beautiful Bill Act, which, among other things, included significant funding cuts and policy changes to Medicaid, which could have a material adverse effect on the ability of our tenants to pay us rent, the profitability of our managed senior living communities a” · word for word

Manager Concentration Risk

“The senior living communities in our SHOP segment managed by Sinceri Senior Living, Discovery Senior Living, Tutera Senior Living, Charter Senior Living and Phoenix Senior Living represented 30.8%, 23.7%, 8.9%, 7.0% and 5.7%, respectively, of our gross real estate value as of December 31, 2025.” · word for word

Interest Rate and Economic Sensitivity

“The impact of unfavorable market and commercial real estate industry conditions due to possible reduced demand for healthcare related space and senior living communities, uncertainties surrounding interest rates, wage and commodity price inflation, supply chain disruptions, changing tariffs and trade policies and related uncertainty, geopolitical instability” · word for word
Read the original on SEC EDGAR ↗
23 Feb 20268-K · 2.02Same property SHOP NOI $38M (+28% y/y)earningsopen

Figures in the filing · each found in the filing text

Same property SHOP NOI · SHOP · Q4-2025$38M+28% y/y

Guidance

Full Year 2026 Guidance provided; positive momentum cited

Risks flagged

No material risk signals identified

“Results at high end of expectations”
Read the original on SEC EDGAR ↗
14 Jan 20268-K · 2.02, 8.01Diversified Healthcare Trust disclosed an incentive management fee of $17.9M for 2025 and a $27.2M cash dividend from AlerisLife's asset sale wind-down, with expected additional $3-7M.open

Figures in the filing · each found in the filing text

Incentive Management Fee · FY2025$18M
Dividend from AlerisLife · 2026-01-09$27M

Risks flagged

Dependence on AlerisLife wind-down for additional cash; amount uncertain.

“We expect to receive an additional cash dividend of approximately $3.0 million to $7.0 million at the completion of the wind-down.” · word for word
Read the original on SEC EDGAR ↗
5 Jan 20268-K · 1.02Terminated a material definitive agreement, ending a significant contract; filed financial statements and exhibits with this reportopen

Risks flagged

Operational disruption risk from transitioning 116 communities to new managers.

“transitioned the management of 116 of our senior living communities ... to seven different third party managers”

Loss of AlerisLife's management expertise and potential revenue impact.

“mutually terminated our management agreements for our senior living communities managed by AlerisLife” · word for word
Read the original on SEC EDGAR ↗
8 Dec 20258-K · 7.01Issued a Regulation FD disclosure (forward guidance or material update); filed financial statements and exhibits with this reportSEC ↗
3 Nov 202510-QDHC reported Q3 2025 results with SHOP segment improvement but higher impairments and net loss.earningsopen

Figures in the filing · each found in the filing text

SHOP Occupancy · SHOP · Q3-202581.5%
SHOP Average Monthly Rate · SHOP · Q3-2025$5472.00+5% y/y
SHOP NOI · SHOP · Q3-2025$30M+8% y/y
Medical Office and Life Science Occupancy · Medical Office and Life Science Portfolio · Q3-202586.6%
Medical Office and Life Science NOI · Medical Office and Life Science Portfolio · Q3-2025$27M-4% y/y
Total Revenue · Q3-2025$389M+4% y/y
Net Loss · Q3-2025$-164M+66% y/y

Risks flagged

Management Transition Disruption

“We may experience temporary disruption, including reductions in our cash flows, as we transition these communities from Five Star.” · word for word

Interest Rate and Inflation Uncertainty

“We are closely monitoring the impacts of the current economic and market conditions on all aspects of our business, including, but not limited to, uncertainties surrounding interest rates and inflation, volatility in the public debt and equity markets, global geopolitical hostilities and tensions, any U.S. government shutdown, economic uncertainties and tari” · word for word

Asset Impairment Risk

“Impairment of assets $93,243 vs $23,031 YoY.”
Read the original on SEC EDGAR ↗
3 Nov 20258-K · 2.02Released earnings results and quarterly financials; filed financial statements and exhibits with this reportearningsopen

Risks flagged

Healthcare REIT exposure; senior living and medical office performance

“Portfolio includes SHOP (senior living) and medical office/life science segments”
Read the original on SEC EDGAR ↗

Diversified Healthcare Trust — questions

What did Diversified Healthcare Trust file recently?
17 SEC filings in the last 12 months. Latest: SC 13D/A on 2026-08-12 — H/2 Special Opportunities IV L.P. reduced its stake in Diversified Healthcare Trust to below 5%, selling 750,000 shares, indicating reduced conviction or exit.

Every figure on this page comes from Diversified Healthcare Trust's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.